Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001707451-18-000003
Filing Date
2018-01-11
Accepted
2018-01-10 21:42:45
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-1 AMENDMENT axium_s1a6.htm S-1/A 671313
2 GRAPHIC image_001.jpg GRAPHIC 4418
3 GRAPHIC image_003.jpg GRAPHIC 2311
4 GRAPHIC image_002.jpg GRAPHIC 2231
5 LEGAL OPINION axium_s1a-ex0501.htm EX-5.1 9301
6 CONSENT axium_ex2302.htm EX-23.2 3339
  Complete submission text file 0001707451-18-000003.txt   697709
Mailing Address 265 EASTCHESTER DR. SUITE 133, #201 HIGHPOINT NC 27262
Business Address 265 EASTCHESTER DR. SUITE 133, #201 HIGHPOINT NC 27262 888-805-7734
Axium Pharmaceuticals Inc. (Filer) CIK: 0001715028 (see all company filings)

EIN.: 821984738 | State of Incorp.: NC | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-220076 | Film No.: 18522596
SIC: 2836 Biological Products, (No Diagnostic Substances)